Insights

Washington – December 5, 2025: Crowell & Moring's Lauren Fleming has been named the 2025 DC Family Law Volunteer of the Year by Volunteer Legal Advocates (VLA), formerly known as DCVLP. This award honors Fleming's exceptional contributions to VLA’s mission to end the cycle of violence by providing pro bono legal services for survivors of domestic violence and at-risk children.

Washington – June 21, 2024: Human Rights First honored Crowell & Moring lawyers Alexis Gilman, Tai Williams, Lauren Fleming, and Amber Gonzales with the Pro Bono Star Award in recognition of their teamwork and extraordinary commitment to representing and protecting asylum seekers. The group was honored at Human Rights First’s World Refugee Day Open House on June 20 in Washington, D.C.

The FTC notched a recent win in federal court, securing a permanent injunction halting the combination of the two dominant brands of construction adhesives, Loctite and Liquid Nails.  In the recently unsealed decision, the court focused on the extensive head-to-head competition between the parties and the importance of brand equity in siding with the FTC, offering important lessons for merging parties.   

On March 19, 2026, a U.S. District Court for the Fifth Circuit panel denied the Federal Trade Commission’s (FTC) emergency motion for a stay pending appeal of a district court’s order that vacated the FTC’s 2024 overhaul of the HSR premerger notification form.

On February 20, 2026, the Department of Justice’s Antitrust Division (DOJ) and Ohio Attorney General (Ohio AG) sued OhioHealth Corporation (OhioHealth), alleging that OhioHealth had unlawfully restrained trade in the market for general acute care inpatient hospital services in the Columbus metropolitan statistical area and the narrower Central Columbus area, respectively. The DOJ and Ohio AG allege violations of Section 1 of the Sherman Act, as well as the Valentine Act (Ohio’s antitrust statute), claiming that OhioHealth leveraged its market power to impose contractual restrictions that blocked payors from working with competing health systems to design “budget-conscious” lower-cost health plans.